Monday, September 29, 2008

Piramal Life Sciences, part of the Piramal Group of companies, has received regulatory approval for initiation of Phase I study of a new cancer molecule P-1446A-05 in Canada`.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)